- Home
- BMR vs IMUX Comparison
BMR vs IMUX Comparison
Compare BMR & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- IMUX
- Stock Information
- Founded
- BMR 2009
- IMUX 2016
- Country
- BMR Israel
- IMUX United States
- Employees
- BMR N/A
- IMUX N/A
- Industry
- BMR Computer Software: Prepackaged Software
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- IMUX Health Care
- Exchange
- BMR Nasdaq
- IMUX Nasdaq
- Market Cap
- BMR 59.3M
- IMUX 67.8M
- IPO Year
- BMR 2023
- IMUX N/A
- Fundamental
- Price
- BMR $3.35
- IMUX $0.73
- Analyst Decision
- BMR
- IMUX Strong Buy
- Analyst Count
- BMR 0
- IMUX 6
- Target Price
- BMR N/A
- IMUX $11.60
- AVG Volume (30 Days)
- BMR 1.0M
- IMUX 2.5M
- Earning Date
- BMR 08-05-2025
- IMUX 08-07-2025
- Dividend Yield
- BMR N/A
- IMUX N/A
- EPS Growth
- BMR N/A
- IMUX N/A
- EPS
- BMR N/A
- IMUX N/A
- Revenue
- BMR $3,064,000.00
- IMUX N/A
- Revenue This Year
- BMR $21.21
- IMUX N/A
- Revenue Next Year
- BMR N/A
- IMUX N/A
- P/E Ratio
- BMR N/A
- IMUX N/A
- Revenue Growth
- BMR 5.33
- IMUX N/A
- 52 Week Low
- BMR $1.86
- IMUX $0.56
- 52 Week High
- BMR $6.59
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- BMR 59.12
- IMUX 41.51
- Support Level
- BMR $2.98
- IMUX $0.68
- Resistance Level
- BMR $3.20
- IMUX $0.74
- Average True Range (ATR)
- BMR 0.22
- IMUX 0.06
- MACD
- BMR -0.01
- IMUX 0.00
- Stochastic Oscillator
- BMR 88.33
- IMUX 27.32
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.